96
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Combined Measure of the Triglyceride Glucose Index and Trimethylamine N-Oxide in Risk Stratification of ST-Segment Elevation Myocardial Infarction Patients with High-Risk Plaque Features Defined by Optical Coherence Tomography: A Substudy of the OCTAMI Registry Study

, , ORCID Icon, , , , , , , , & ORCID Icon show all
Pages 141-155 | Received 16 Nov 2023, Accepted 10 Mar 2024, Published online: 30 Mar 2024

References

  • Zhou M, Liu J, Hao Y, et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the improving care for cardiovascular disease in china-acute coronary syndrome project. Cardiovasc Diabetol. 2018;17(1):147.
  • Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001–2015. doi:10.1056/NEJMoa0706482
  • Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387–2397. doi:10.1056/NEJMoa1410489
  • Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Com- parison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351. doi:10.1210/jc.2010-0288
  • Mazidi M, Kengne AP, Katsiki N, Mikhailidis DP, Banach M. Lipid accumula- tion product and triglycerides/glucose index are useful predictors of insulin resistance. J Diabetes Complicat. 2018;32(3):266–270. doi:10.1016/j.jdiacomp.2017.10.007
  • Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glu- cose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13(1):146. doi:10.1186/s12933-014-0146-3
  • Da Silva A, Caldas APS, Hermsdorf HHM, et al. Triglyceride-glucose index is associated with sympto- matic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019;18(1):89. doi:10.1186/s12933-019-0893-2
  • Li S, Guo B, Chen H, et al. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis. Sci Rep-Uk. 2019;9(1):7320. doi:10.1038/s41598-019-43776-5
  • Cho Y, Ann SH, Won K, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep-Uk. 2019;9(1):6129. doi:10.1038/s41598-019-42700-1
  • Lee EY, Yang HK, Lee J, et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 2016;15(1):155. doi:10.1186/s12944-016-0324-2
  • Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63. doi:10.1038/nature09922
  • Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–1584. doi:10.1056/NEJMoa1109400
  • Heianza Y, Ma W, Manson JE, et al. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Heart Assoc. 2017;6(7):e004947. doi:10.1161/JAHA.116.004947
  • Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working group for intravascular optical coherence tomography standardization and validation. J Am Coll Cardiol. 2012;59(12):1058–1072.
  • Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50(10):933–939. doi:10.1016/j.jacc.2007.04.082
  • Stone GW, Maehara A, Lansky AJ, et al. Prospect Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–235. doi:10.1056/NEJMoa1002358
  • Xing L, Higuma T, Wang Z, et al. Clinical significance of lipid-rich plaque detected by optical coherence tomography: a 4-year follow-up study. J Am Coll Cardiol. 2017;69:2502–2513. doi:10.1016/j.jacc.2017.03.556
  • Waksman R. on behalf of the LRP investigators. Assessment of coronary near infrared spectroscopy imaging to detect vulnerable plaques and vulnerable patients. Late breaking trial. TCT. 2018;2018:1.
  • Ibanez B, James S, Agewall S, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177. doi:10.1093/eurheartj/ehx393
  • Aronow WS. Hypertension guidelines. Hypertension. 2011;58(3):347–348. doi:10.1161/HYPERTENSIONAHA.111.177147
  • Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–877. doi:10.2337/dc16-0236
  • Shrank WH, Barlow JF, Brennan TA. New therapies in the treatment of high cholesterol: an argument to return to goal-based lipid guidelines. JAMA. 2015;314(14):1443–1444. doi:10.1001/jama.2015.10017
  • Lin L, Zhao J, Hu J, et al. Current smoking has a detrimental effect on survival for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) negative Advanced non-squamous Non-small Cell Lung Cancer (NSCLC) patients treated with pemetrexed continuation maintenance. J Cancer. 2018;9(12):2140–2146. doi:10.7150/jca.24872
  • Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Sesti G. Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage. BMJ Open Diabetes Res Care. 2019;7(1):e000911. doi:10.1136/bmjdrc-2019-000911
  • Tian J, Ren X, Vergallo R, et al. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol. 2014;63(21):2209–2216. doi:10.1016/j.jacc.2014.01.061
  • Prati F, Regar E, Mintz GS, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010;31:401–415. doi:10.1093/eurheartj/ehp433
  • Wang Z, Levison BS, Hazen JE, Donahue L, Li XM, Hazen SL. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem. 2014;455:35–40. doi:10.1016/j.ab.2014.03.016
  • Brahimaj A, Rivadeneira F, Muka T, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;62(9):1581–1590. doi:10.1007/s00125-019-4921-2
  • Zhang M, Wang B, Liu Y, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the rural Chinese cohort study. Cardiovasc Diabetol. 2017;16(1):30. doi:10.1186/s12933-017-0514-x
  • Su W, Chen S, Huang Y, et al. Comparison of the effects of fasting glucose, hemoglobin A1c, and triglyceride-glucose index on cardiovascular events in type 2 diabetes mellitus. Nutrients. 2019;11(11):2838. doi:10.3390/nu11112838
  • Ma X, Dong L, Shao Q, et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):31. doi:10.1186/s12933-020-01006-7
  • Zhao X, Wang Y, Chen R, et al. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Cardiovasc Diabetol. 2021;20(1):131. doi:10.1186/s12933-021-01321-7
  • Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576–585. doi:10.1038/nm.3145
  • Koeth RA, Levison BS, Culley MK, et al. gamma-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 2014;20:799–812. doi:10.1016/j.cmet.2014.10.006
  • Rodes-Cabau J, Gutierrez M, Courtis J, et al. Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis in the proximal-mid segment of a coronary artery by myocardial fractional flow reserve measurements. Am J Cardiol. 2011;108:483–490. doi:10.1016/j.amjcard.2011.03.073
  • Wang Z, Roberts AB, Buffa JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163:1585–1595. doi:10.1016/j.cell.2015.11.055
  • Guo Y, Hwang L-D, Li J, et al. Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing. BMC Med Genet. 2017;18(1):11. doi:10.1186/s12881-017-0369-8
  • Randrianarisoa E, Lehn-Stefan A, Wang X, et al. Relationship of serum trimethylamine NOxide (TMAO) levels with early atherosclerosis in humans. Sci Rep. 2016;6:26745. doi:10.1038/srep26745
  • Wang Z, Bergeron N, Levison BS, et al. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J. 2019;40:583–594. doi:10.1093/eurheartj/ehy799
  • Heianza Y, Ma W, A DJ, et al. Long-term changes in gut microbial metabolite trimethylamine N-oxide and coronary heart disease risk. J Americ Coll Cardio. 2020;75(7):763–772. doi:10.1016/j.jacc.2019.11.060
  • Jiao N, Baker SS, Nugent CA, et al. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis. Physiol Genomics. 2018;50(4):244–254. doi:10.1152/physiolgenomics.00114.2017
  • Hartstra AV, Bouter KE, Backhed F, Nieuwdorp M. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care. 2015;38(1):159–165. doi:10.2337/dc14-0769
  • Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718–15723. doi:10.1073/pnas.0407076101
  • Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031. doi:10.1038/nature05414
  • Warwick BP, Romsos DR. Energy balance in adrenalectomized ob/ob mice: effects of dietary starch and glucose. Am J Physiol Regul Integr Comp Physiol. 1988;255:R141–R148. doi:10.1152/ajpregu.1988.255.1.R141
  • Neis EP, Dejong CH, Rensen SS. The role of microbial amino acid metabolism in host metabolism. Nutrients. 2015;7:2930–2946. doi:10.3390/nu7042930
  • Zhao L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol. 2013;11:639–647. doi:10.1038/nrmicro3089